Compare NEON & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEON | VNRX |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 24.5M |
| IPO Year | 1994 | 2012 |
| Metric | NEON | VNRX |
|---|---|---|
| Price | $0.89 | $0.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $6.00 | $1.67 |
| AVG Volume (30 Days) | 104.9K | ★ 242.8K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.88 | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,108,000.00 | $1,727,384.00 |
| Revenue This Year | $72.74 | $355.66 |
| Revenue Next Year | $28.94 | $849.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $0.72 | $0.13 |
| 52 Week High | $26.95 | $3.26 |
| Indicator | NEON | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 29.02 |
| Support Level | $0.73 | $0.19 |
| Resistance Level | $1.05 | $1.55 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 82.26 | 12.26 |
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.